Alterity Therapeutics
(NASDAQ) ATHE
Alterity Therapeutics Financials at a Glance
Market Cap
$1.94M
Revenue (TTM)
A$7.56M
Net Income (TTM)
-A$34.20M
EPS (TTM)
-$28.95
P/E Ratio
-0.19
Dividend
$0.00
Beta (Volatility)
0.69 (Low)
Dividend
$0.00
Beta (Volatility)
0.69 (Low)
Price
$5.33
Volume
596
Open
$5.43
Price
$5.33
Volume
596
Open
$5.43
Previous Close
$5.33
Daily Range
$5.33 - $5.43
52-Week Range
$2.66 - $7.00
Estimated Earnings Date
Aug 28, 2026
Dividend
$0.00
Beta (Volatility)
0.69 (Low)
Price
$5.33
Volume
596
Open
$5.43
Previous Close
$5.33
Daily Range
$5.33 - $5.43
52-Week Range
$2.66 - $7.00
Estimated Earnings Date
Aug 28, 2026
ATHE News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Alterity Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
9
CEO
David A. Stamler, MD
Website
www.alteritytherapeutics.comHeadquarters
Melbourne, VIC 3000, AU
ATHE Financials
Key Financial Metrics (TTM)
Gross Margin
96.82%
Operating Margin
-525.58%
Net Income Margin
-380.65%
Return on Equity
-30.19%
Return on Capital
-34.25%
Return on Assets
-25.63%
Earnings Yield
-5.26%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.94M
Shares Outstanding
362.50K
Volume
596
Avg. Volume
51.18K
Financials (TTM)
Gross Profit
A$7.30M
Operating Income
-A$40.38M
EBITDA
-A$42.01M
Operating Cash Flow
-A$29.25M
Capital Expenditure
A$10.43M
Free Cash Flow
-A$18.83M
Cash & ST Invst.
A$49.15M
Total Debt
A$98.35K
Alterity Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
A$0.00
-100.0%
Gross Profit
-A$56.83K
-103.1%
Gross Margin
0.00%
N/A
Market Cap
$1.94M
N/A
Market Cap/Employee
$194.31K
N/A
Employees
10
N/A
Net Income
-A$9.44M
-45.1%
EBITDA
-A$12.76M
-53.1%
Quarterly Fundamentals
Total Cash
A$49.15M
+298.9%
Total Debt
A$98.35K
-61.5%
Accounts Receivable
A$6.84M
+17.7%
Inventory
A$0.00
N/A
Long Term Debt
A$65.40K
-14.5%
Short Term Debt
A$32.96K
-81.6%
Return on Assets
-25.63%
N/A
Return on Invested Capital
-37.08%
N/A
Free Cash Flow
A$0.00
+100.0%
Operating Cash Flow
-A$10.43M
-131.9%